Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+11.5%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+11.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 92.30% |
| 2024 | -33.67% |
| 2023 | 44.89% |
| 2022 | 66.59% |
| 2021 | 26.72% |
| 2020 | -37.61% |
| 2019 | -62.68% |
| 2018 | -123.50% |
| 2017 | 43.34% |
| 2016 | -123.58% |